Abstract:Background/Aims: The purpose of this study was to probe the clinico-pathological significance and the underlying mechanism of miR-30d-5p expression in non-small cell lung cancer (NSCLC). Methods: We initially examined the level of miR-30d-5p expression in NSCLC and non-cancer tissues using RT-qPCR. Then, a series of validation analyses including a meta-analysis of data from microarray chips in Gene Expression Omnibus (GEO), data mining of the cancer genome atlas (TCGA) and an integrated meta-analysis incorporating GEO microarray chips, TCGA data, in-house RT-qPCR and literature studies were performed to examine the clinico-pathological value of miR-30d-5p expression in NSCLC. In vitro experiments were further conducted to investigate the impact of miR-30d-5p on NSCLC cell growth. The molecular mechanism by which miR-30d-5p regulates the pathogenesis of NSCLC was probed through a bioinformatics analysis of its target genes. Moreover, dual luciferase reporter assay was conducted to verify the targeting regulatory relationship between miR-30d-5p and CCNE2. Results: Based on results from RT-qPCR, GEO meta-analysis, TCGA data mining and the integrated meta-analysis incorporating GEO microarray chips, TCGA data, in-house RT-qPCR and literature studies, miR-30d-5p expression was decreased in NSCLC tissues, and patients with NSCLC who presented with lower miR-30d-5p expression tended to display an advanced clinical progression. Significant pathways including the Mucin type O-glycan biosynthesis pathway, cell cycle pathway and cysteine and methionine metabolism pathway (all P< 0.05) revealed potential roles of the target genes of miR-30d-5p in the oncogenesis of NSCLC. Results from in vitro experiments indicated that miR-30d-5p could attenuate proliferation and viability of NSCLC cells. Among the 12 identified hub genes, nine genes including E2F3, CCNE2, SKP2, CDK6, TFDP1, LDHA, GOT2, DNMT3B and ST6GALNAC1 were validated by Pearson’s correlation test and the human protein atlas (HPA) database as targets of miR-30d-5p with higher probability. Specifically, dual luciferase reporter assay confirmed that CCNE2 was directly targeted by miR-30d-5p. Conclusion: In summary, miR-30d-5p expression is decreased in NSCLC, and it might play the role as tumor suppressor in NSCLC by regulating target genes.

Down-Regulation of Mir-4500 Promoted Non-Small Cell Lung Cancer Growth

Down-Regulation of Mir-452 is Associated with Poor Prognosis in the Non-Small-Cell Lung Cancer

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Mir‑654‑3p Suppresses Cell Viability and Promotes Apoptosis by Targeting RASAL2 in Non‑small‑cell Lung Cancer.

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

Downregulation of Hsa-Microrna-204-5p and Identification of Its Potential Regulatory Network in Non-Small Cell Lung Cancer: RT-qPCR, Bioinformatic- and Meta-Analyses.

Decreased Expression of Mir216a Contributes to Non-Small-Cell Lung Cancer Progression

Deregulated Expression of Mir-21, Mir-143 and Mir-181A in Non Small Cell Lung Cancer is Related to Clinicopathologic Characteristics or Patient Prognosis

The Suppressive Role of Mir-542-5p in NSCLC: the Evidence from Clinical Data and in Vivo Validation Using a Chick Chorioallantoic Membrane Model

The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.

The Novel Mir-9501 Inhibits Cell Proliferation, Migration and Activates Apoptosis in Non-Small Cell Lung Cancer

miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by targeting TGFBR1 and CCNE2

Up-regulated miR-196a promotes non-small cell lung cancer cells proliferation by regulating p27~(kip1) expression

Mir‑146a‑5p Targets TCSF and Influences Cell Growth and Apoptosis to Repress NSCLC Progression

Expression Signature and Role of Mir-30D-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments

Down-regulation of MBNL1-AS1 Contributes to Tumorigenesis of NSCLC Via Sponging Mir-135A-5p

Reduced Mir-105-1 Levels Are Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer.

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

Downregulation of Hsa_circtlk1 Represses Non-Small Cell Lung Cancer Progression by Regulating Mir-876-3p/srsf7 Axis

Up-Regulation Of Mir-182-5p Predicts Poor Prognosis In Patients With Lung Cancer And Associates With Tumor Cell Growth And Migration